Streamlining Borrelia burgdorferi cultivation using quantitative PCR screening
Journal of Medical Microbiology · 2026
DOI: 10.1099/jmm.0.002123 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Journal of Medical Microbiology, 2026. Verfasst von Beat M Greiter und 14 weiteren Autor:innen. Beteiligte Einrichtung: Division of Infectious Diseases and Hospital Epidemiology, Children's Research Center, University Children's Hospital Zurich, University of Zurich, Z…. Hauptthemen laut MEDLINE: Borrelia burgdorferi, Bacteriological Techniques, Lyme Disease. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: research grant from the Children’s Research Center of the University Children’s Hospital Zurich, EMDO Stiftung.
Abstract (Originalsprache)
Introduction
Direct detection of Borrelia burgdorferi by culture is considered the gold standard for confirming Lyme disease (LD). However, B. burgdorferi culture is not routinely used in clinical practice or research due to its lengthy protocol and low success rate. This study aimed to streamline the process by integrating a specific quantitative PCR (qPCR) screening early into the B. burgdorferi culture workflow for identification of cultures that are likely to yield viable spirochetes.
Methods
Thirty-two blood plasma and 11 cerebrospinal fluid (CSF) samples were collected from 32 children with serologically confirmed LD and incubated in modified Kelly-Pettenkofer medium for up to 9 weeks, with weekly assessments for viable spirochetes using microscopy. After 3 weeks, the presence of B. burgdorferi DNA in culture was assessed by qPCR targeting the B. burgdorferi flagellin B gene. The estimated copy number of the target template was compared to the assay’s 95% limit of detection (LOD).
Results
After 9 weeks of incubation, viable spirochetes were observed in 2 ( n =2/32, 6.3%) plasma cultures and 3 ( n =3/11, 27.3%) CSF cultures. These were only observed in cultures showing copy numbers above 95% LOD in qPCR testing at week 3 ( n =2/3 plasma cultures, 66.7%; n =3/3 CSF cultures, 100.0%).
Conclusion
Culturing B. burgdorferi is challenging and, despite a high workload, often not successful. qPCR may serve as an effective screening tool for B. burgdorferi cultures, enabling the culturing process to be streamlined by prioritizing cultures with target copy numbers exceeding the 95% LOD of the qPCR assay.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Infectious Diseases and Hospital Epidemiology, Children's Research Center, University Children's Hospital Zurich, University of Zurich, Zurich, Switzerland.
- Emergency Department, University Children's Hospital Zurich, Zurich, Switzerland.
- Institute of Medical Microbiology, University of Zurich, Zurich, Switzerland.
Förderung
- research grant from the Children’s Research Center of the University Children’s Hospital Zurich
- EMDO Stiftung
Zitieren
APA
Greiter, B. M., Sidorov, S., Osuna, E., Schalch, A., Greiter, L. M., Robinson, E., Seiler, M., Bressan, M., Imkamp, F., Beer, O. S., Ens, L., Nolte, O., Egli, A., Berger, C., & Meyer Sauteur, P. M. (2026). Streamlining Borrelia burgdorferi cultivation using quantitative PCR screening. Journal of Medical Microbiology. https://doi.org/10.1099/jmm.0.002123
Vancouver
Greiter BM, Sidorov S, Osuna E, Schalch A, Greiter LM, Robinson E, et al. Streamlining Borrelia burgdorferi cultivation using quantitative PCR screening. Journal of Medical Microbiology. 2026. doi:10.1099/jmm.0.002123
BibTeX
@article{Greiter2026,
author = {Greiter, Beat M and Sidorov, Semjon and Osuna, Ester and Schalch, Annina and Greiter, Lisa M and Robinson, Elena and Seiler, Michelle and Bressan, Michelle and Imkamp, Frank and Beer, Oliver S and Ens, Leslie and Nolte, Oliver and Egli, Adrian and Berger, Christoph and Meyer Sauteur, Patrick M},
title = {Streamlining Borrelia burgdorferi cultivation using quantitative PCR screening},
journal = {Journal of Medical Microbiology},
year = {2026},
doi = {10.1099/jmm.0.002123}
}
EUVIMED